NCT07340255

Brief Summary

Exploring the 90% Effective Ventilation Pressure (EP90) for Esophageal Insufflation Avoidance During Anesthesia Induction: The aim is to determine the optimal ventilation pressure for esophageal insufflation avoidance during anesthesia induction and to explore its guiding significance for anesthesia management. The goal is to provide a more precise and personalized ventilation pressure setting standard for clinical anesthesia, thereby enhancing the safety of the anesthesia induction phase.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

September 29, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

September 28, 2025

Last Update Submit

January 13, 2026

Conditions

Keywords

Esophageal InsufflationAirway ManagementVentilationBias-coin Design

Outcome Measures

Primary Outcomes (1)

  • EP90

    The 90% effective ventilation pressure (EP90) for avoiding esophageal inflation refers to the minimum effective airway pressure (measured in cmH₂O) at which 90% of patients do not experience esophageal inflation during pressure-controlled mask ventilation during anesthesia induction.

    Perioperative

Secondary Outcomes (9)

  • EP95

    Periprocedural

  • EP98

    Periprocedural

  • Ventilation-related respiratory parameters

    Periprocedural

  • Ventilation-related respiratory parameters

    Periprocedural

  • Ventilation-related respiratory parameters

    Periprocedural

  • +4 more secondary outcomes

Study Arms (1)

Ventilation Pressure

EXPERIMENTAL

Anesthesia machine settings: pressure control mode, inspiratory-to-expiratory ratio of 1:2, respiratory rate of 15 breaths/min, 100% oxygen, no PEEP applied. Mask ventilation duration was standardized to 120 seconds, followed by tracheal intubation.

Other: Ultrasonic and inflation determination

Interventions

Before induction, during ventilation, and after intubation, the anesthesiologist used a 7-14 MHz linear array probe for transverse (supraclavicular) positioning to monitor the left paratracheal esophageal region in real time. The main criterion for assessment was the absence of esophageal gas during ventilation, which was considered a positive response. If gas was detected entering the esophagus on ultrasound, it was recorded as a negative response. Additionally, the anesthesiologist performed a preoperative ultrasound examination of the gastric antrum to record baseline gastric antrum parameters. After successful tracheal intubation, a follow-up ultrasound of the gastric antrum was conducted to obtain postoperative gastric antrum parameters.

Ventilation Pressure

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-65 years, regardless of gender;
  • ASA classification: I-III;
  • Scheduled for elective general anesthesia surgery;
  • BMI: 18.0-28.0 kg/m²;
  • Preoperative fasting: Solid food \>6 hours, liquid \>2 hours;
  • Less than two from five criteria predicting difficult mask ventilation as described by Langeron et al.(Prediction of difficult mask ventilation. Anesthesiology 2000; 92:1229-36);
  • No severe underlying conditions such as heart, lung, liver, or kidney disease;
  • Signed informed consent and ability to cooperate with the study protocol.

You may not qualify if:

  • Pregnant or breastfeeding women;
  • History of upper gastrointestinal diseases such as gastroesophageal reflux disease, peptic ulcers, or hiatal hernia;
  • Recent (within 2 weeks) respiratory infections, chronic cough, similar symptoms, and other known or predictable respiratory system diseases;
  • Need for emergency surgery or airway obstruction after anesthesia induction requiring urgent intubation;
  • Inability to achieve adequate oxygenation during mask ventilation (e.g., SpO₂ \< 92% for 30 seconds, unresponsive to treatment);
  • History of contraindications or allergies to study medications;
  • Inability to understand the study content or refusal to cooperate;
  • Oropharyngeal or facial pathology;
  • with an indwelling gastric tube, and who had previously undergone gastric surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Jiaxing University

Jiaxing, China

RECRUITING

Related Publications (1)

  • Langeron O, Masso E, Huraux C, Guggiari M, Bianchi A, Coriat P, Riou B. Prediction of difficult mask ventilation. Anesthesiology. 2000 May;92(5):1229-36. doi: 10.1097/00000542-200005000-00009.

MeSH Terms

Conditions

Respiratory Aspiration

Interventions

High-Energy Shock Waves

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Officials

  • Qinghe Zhou, Dr.

    Affiliated Hospital of Jiaxing University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Head of Anesthesiology

Study Record Dates

First Submitted

September 28, 2025

First Posted

January 14, 2026

Study Start

September 29, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

January 14, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations